| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/08/2007 | CN1330643C Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl)-amine derivatives |
| 08/08/2007 | CN1330640C Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 08/08/2007 | CN1330638C Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them |
| 08/08/2007 | CN1330633C Pyrrolidine derivatives as oxytocin antagonists |
| 08/08/2007 | CN1330307C Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 08/08/2007 | CN101014590A 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
| 08/08/2007 | CN101014588A Pyrrole derivatives, their preparation and their therapeutic use |
| 08/08/2007 | CN101014587A Substituted biaryl piperazinyl-pyridine analogues |
| 08/08/2007 | CN101014578A 三唑衍生物或其盐 Triazole derivative or salt thereof |
| 08/08/2007 | CN101014575A Sigma receptor inhibitors |
| 08/08/2007 | CN101014343A Tetracyclic lactam derivatives and uses thereof |
| 08/08/2007 | CN101014338A 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2, 4-dione and analogues as inhibitors of macrophage elastase |
| 08/08/2007 | CN101012223A Ornidazole derivative for treatment, preparing method and use |
| 08/08/2007 | CN101012203A 1,2,4-triazol derivatives, method for preparing the same |
| 08/08/2007 | CN101012200A Process for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
| 08/07/2007 | US7253290 3-[2,2-dimethyl-3-oxo-3-(7-azabicyclo[2.2.1]heptan-7-yl)propoxy]-4-[(1S)-1-methyl-2-[(isopropoxycarbonyl)imino(-3-pyridin-4-yl-pyrrolidin-1-yl)methyl]aminoethyl]-5-(3,5-dimethylphenyl)-1H-pyrazole; prodrugs for treating prostatic cancer, uterine cancer, breast cancer and pituitary gonadotrophe adenoma |
| 08/07/2007 | US7253203 Indoline derivatives |
| 08/07/2007 | US7253201 Small molecule inhibitors of necrosis |
| 08/07/2007 | US7253200 Using in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions |
| 08/07/2007 | US7253198 Hydroxyethylamine derivatives for the treatment of Alzheimer's disease |
| 08/07/2007 | US7253190 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders |
| 08/07/2007 | US7253188 Aminobenzamide derivative |
| 08/07/2007 | US7253187 Heterocyclic inhibitors of ERK2 and uses thereof |
| 08/07/2007 | US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253170 Pyrazole-amine compounds useful as kinase inhibitors |
| 08/07/2007 | CA2302943C Phthalazine compounds and therapeutic agents for erectile dysfunction |
| 08/02/2007 | WO2007087488A2 Indole sulfonamide modulators of progesterone receptors |
| 08/02/2007 | WO2007087276A1 Aurora kinase modulators and method of use |
| 08/02/2007 | WO2007087130A2 Hydroxyalkylarylamide derivatives |
| 08/02/2007 | WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K |
| 08/02/2007 | WO2007085540A1 1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives |
| 08/02/2007 | WO2007085205A1 Pyrrole substituted 2-indolinone derivatives, the preparation methods and medical uses thereof |
| 08/02/2007 | WO2007063702A3 Iminopropene compound and use thereof |
| 08/02/2007 | WO2007052073A3 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
| 08/02/2007 | WO2007017602A3 Marqueurs, leur procede de fabrication et leurs applications |
| 08/02/2007 | WO2007017469A3 Process for preparing an angiotensin ii receptor antagonist |
| 08/02/2007 | WO2006081391A3 Compounds for inflammation and immune-related uses |
| 08/02/2007 | US20070179298 Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds |
| 08/02/2007 | US20070179192 Thrombopoietin mimetics |
| 08/02/2007 | US20070179189 Bridged tricyclic (e.g 9,10-ethanoanthracene) derivatives of (2-carbonylamino)thiazol-5-yloxoacetamides; treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity including obesity, diabetes, inflammatory and immune diseases |
| 08/02/2007 | US20070179182 Chronic neuropathic and visceral pain, adrenergic receptors, side effect reduction; glaucoma or ocular hypertension by topical ophthalmic administration |
| 08/02/2007 | US20070179180 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/02/2007 | US20070179156 3-(isoquinolin-1-ylamino)-5-(6-(methylamino)pyrazin-2-yl)pyridin-2(1H)-one; autoimmune, inflammatory, proliferative, or hyperproliferative disease or an immunologically-mediated disease |
| 08/02/2007 | US20070179153 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 08/02/2007 | US20070179151 (1-Isopropyl-6-methoxy-isoquinolin-3-yl)-(5-methyl-1H-pyrazol-3-yl)-amine; (5-Cyclopropyl-1H-pyrazol-3-yl)-(1-isopropyl-6,7-dimethoxy-isoquinolin-3-yl)-amine; Aurora kinase inhibitors; cancer |
| 08/02/2007 | US20070179150 Nitrosated proton pump inhibitors, compositions and methods of use |
| 08/02/2007 | US20070179146 2-{4-[3-(3,4-dimethoxy-phenyl)-5.5-dimethyl-6-oxa-5,6-dihydro-4H-pyridazin-1-yl]-piperidine-1-sulfonyl}-benzonitrile; low toxicity, high bioavailability, side effects reduction; antiinflammatory agents; antiallergenic; respiratory disorders |
| 08/02/2007 | US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 08/02/2007 | US20070179141 Therapeutic agents useful for treating pain |
| 08/02/2007 | US20070179140 (1R,2R,3S,4S) N4-(3-Aminocarbonylbicyclo[2.2.1]hept-5-ene-2-yl)-5-fluoro-N2-[3-(1,3-oxazol-2-yl)phenyl]-2,4-pyrimidinediamine, exhibiting antiproliferative, anticarcinogenic or antitumor activity |
| 08/02/2007 | US20070179139 Methyl 4-{[(2-{4-[(4-bromophenoxy)methyl]-2,5-dimethyl-3-thienyl}ethyl)(5-ethoxy-5-oxopentyl)amino]methyl}benzoate, for example; treatment of cardiovascular and other diseases |
| 08/02/2007 | US20070179136 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors |
| 08/02/2007 | US20070179133 Compositions useful as inhibitors of protein kinases |
| 08/02/2007 | US20070179132 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/02/2007 | US20070179122 Beta-Aminoacid-Derivatives As Factor Xa Inhibitors |
| 08/02/2007 | US20070178512 Modified carbocyanine dyes and their conjugates |
| 08/02/2007 | US20070178511 Modified carbocyanine dyes and their conjugates |
| 08/02/2007 | US20070176541 Organic light emitting compound and organic light emitting device comprising the same |
| 08/02/2007 | CA2640375A1 Pyrimidine derivatives |
| 08/02/2007 | CA2637933A1 Indole sulfonamide modulators of progesterone receptors |
| 08/02/2007 | CA2627607A1 Fap inhibitors |
| 08/01/2007 | EP1813651A1 Optical filter |
| 08/01/2007 | EP1813603A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 08/01/2007 | EP1813286A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 08/01/2007 | EP1812424A2 Kinase inhibitors |
| 08/01/2007 | EP1812423A1 Process for the synthesis of tetrazoles |
| 08/01/2007 | EP1812422A1 Polymorph form of irbesartan |
| 08/01/2007 | EP1812410A2 Indinavir derivatives useful in immunoassay |
| 08/01/2007 | EP1812408A2 Pyridazine compounds, compositions and methods |
| 08/01/2007 | EP1812406A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 08/01/2007 | EP1812405A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 08/01/2007 | EP1812403A2 Pyrazolobenzamides and derivatives as factor xa inhibitors |
| 08/01/2007 | EP1812389A1 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 08/01/2007 | EP1812112A2 Chemical compounds |
| 08/01/2007 | EP1581505B1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 08/01/2007 | EP1565456A4 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 08/01/2007 | EP1560811B1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 08/01/2007 | EP1487822B1 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors |
| 08/01/2007 | EP1484327B1 Nitrogenous heterocyclic compound and medicine thereof |
| 08/01/2007 | EP1373194B1 BENZAMIDE INHIBITORS OF FACTOR Xa |
| 08/01/2007 | EP1355904B1 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 08/01/2007 | EP1294698B1 Fused azepine derivatives and their use as antidiuretic agents |
| 08/01/2007 | CN1329380C Trisresorcinyltriazines |
| 08/01/2007 | CN1329378C Compounds useful to treat retroviral infections |
| 08/01/2007 | CN1329375C Novel anti-diabetic agents |
| 08/01/2007 | CN1329374C Compound as CCR5 agonist |
| 08/01/2007 | CN101010318A 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 08/01/2007 | CN101010317A 2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 08/01/2007 | CN101010302A Sigma receptor inhibitors |
| 08/01/2007 | CN101010106A Conjugates of antibody and Duocarmycin derivatives as antitumor agents |
| 08/01/2007 | CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/01/2007 | CN101007801A Pyrrole substituted 2-dihydromolindone derivative, its preparation method and medical uses |
| 08/01/2007 | CN101007778A Chain-prolonged type fluorenyl bimaleimide and its preparation method |
| 07/31/2007 | US7250516 Phenylalanine derivatives |
| 07/31/2007 | US7250513 Heating to isomerize |
| 07/31/2007 | US7250444 Pyrrole-based HMG-CoA reductase inhibitors |
| 07/31/2007 | US7250442 glucocorticoid, androgen, mineralcorticoid, estrogen and progesterone receptor modulators such as 3,3-Bis-(4-hydroxy-3,5-dimethyl-phenyl)-1-(4-methoxy-benzyl)-1,3-dihydro-indol-2-one, used for treating congestive heart failure |
| 07/31/2007 | US7250437 Pyrrazoles connnected to a carbocyclic ring by a vinylene, butadienylene or hexatrienylene bridge, e.g. 3(5)-[2-(2-chloro-5-trifluoromethylphenyl)vinyl]-1H-pyrazole; compounds exhibit antifibrotic and antiapoptotic activities |
| 07/31/2007 | US7250435 5-(Thio)Carbonylamino-indeno[1,2-c]pyrazol-4-ones, e.g., 3-(4-methoxyphenyl)-5-(2-phenethylacetylhydrazine carboxamido)indeno[1,2-c]pyrazol-4-one and 3-(4-methoxyphenyl)-5-(2-methoxycarbonyl hydrazinecarboxamido)indeno[1,2-c]pyrazol-4-one |